ATLANTA -- In select patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes who were event-free for 1 month on dual antiplatelet therapy (DAPT), treatment with ...

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...

SAN FRANCISCO -- For ticagrelor-based antithrombotic regimens after drug-eluting stent implantation for acute coronary syndrome (ACS), stopping aspirin within the first month appeared to be safer than ...

Any Point in Higher Doses of Clopidogrel or Aspirin in ACS? Henry Black, MD, reports on a study comparing clopidogrel and aspirin doses for ACS that strongly suggests that higher may not be better.

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most ...

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone – and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

Despite its well-established role as an antiplatelet drug, clopidogrel is associated with several limitations, including a variability of response that can only partially be overcome by increasing the ...

After coronary bypass for acute coronary syndrome, adding ticagrelor to aspirin did not reduce cardiovascular events but increased major bleeding at 1 year, as compared with aspirin alone.